Neurofeedback (EEG Biofeedback) Training — Cognitive Technologies & Brain Longevity
Real-time EEG-based training that teaches self-regulation of brainwave patterns — FDA-cleared for attention and stress; used for ADHD, cognitive performance, peak performance, and anxiety.
Overview
Neurofeedback is an operant conditioning paradigm in which EEG signals (brainwave activity) are processed in real-time and fed back to the patient as audio or visual reward signals, enabling voluntary regulation of specific brain frequency bands. The patient learns — without conscious effort — to shift their EEG toward therapeutic targets. Theta/beta training (suppressing theta 4-8 Hz, enhancing beta 12-20 Hz) is the most studied protocol for ADHD and has 30+ randomized controlled trials. A 2022 meta-analysis (n=3,067 ADHD participants) found neurofeedback produced effect sizes comparable to stimulant medication for attention and comparable or superior for behavioral outcomes, with lasting effects at 12-month follow-up. Alpha/theta training (promoting relaxed alpha waves) is used for peak performance, creativity, and PTSD. Gamma (40 Hz) training is being investigated for Alzheimer's prevention following MIT's Tsai lab findings that 40 Hz sensory entrainment reduces amyloid and tau. FDA has cleared specific neurofeedback devices for ADHD (EndeavorRx, 2020 — actually a video game but uses attention monitoring) and stress. Home systems (Muse headband, Neurosity Crown, Emotiv) allow consumer-grade practice.
Indications
- ADHD (strongest evidence base — 30+ RCTs for theta/beta training)
- Anxiety and stress management (alpha training)
- Peak performance and cognitive optimization (alpha/theta training)
- PTSD symptom reduction (alpha/theta and infra-low frequency)
- Epilepsy (SMR/sensorimotor rhythm training — historical evidence)
- Learning disabilities and processing speed
Mechanism of Action
Real-time EEG feedback creates an operant conditioning learning loop where the brain receives reward signals for producing desired wave patterns, gradually reshaping the default neural network activity toward therapeutic targets
Dosing
| Compound | Dose | Frequency | Notes |
|---|---|---|---|
| Neurofeedback (clinical protocol) | 30-45 minute sessions | 2-3 sessions per week | Minimum 20 sessions before assessing benefit; 40-session protocol for ADHD typically; clinical qEEG mapping first ($500-1,000); session cost $100-250 each |
| Neurofeedback (home system) | 20-30 minute sessions | Daily or 5x weekly | Limited to 1-2 channels; suitable for alpha/relaxation training and meditation support; insufficient for clinical ADHD treatment; $200-499 hardware |
Evidence Grade
GRADE C
Safety & Contraindications
- Non-invasive and extremely safe — EEG electrodes only detect, not emit, electrical signals
- Rare: initial sessions may cause fatigue, headache, or temporary mood changes as the brain adapts
- Contraindicated with active psychosis or certain epilepsy patterns (training must be supervised by qualified practitioner)
- Home EEG consumer devices (Muse, Emotiv) have insufficient spatial resolution for clinical neurofeedback — good for meditation feedback, not therapeutic training
- Clinical neurofeedback requires 19-channel quantitative EEG (qEEG) brain map to guide personalized protocol